Adverum Biotechnologies, Inc. (ADVM) financial statements (2022 and earlier)

Company profile

Business Address 800 SAGINAW DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:305,200429,729166,035205,079190,485222,170259,080
Cash and cash equivalents34,19562,42465,897154,94970,519222,170221,348
Short-term investments270,993367,305100,13850,130119,966 37,732
Other undisclosed cash, cash equivalents, and short-term investments12      
Receivables     886449
Other undisclosed current assets11,9454,7099,8353,6753,2562,2181,463
Total current assets:317,145434,438175,870208,754193,741225,274260,992
Noncurrent Assets
Operating lease, right-of-use asset86,00019,37620,963
Property, plant and equipment33,06027,72524,8843,5863,0244,1693,187
Intangible assets, net (including goodwill)    5,0005,000 
Intangible assets, net (excluding goodwill)    5,0005,000 
Restricted cash and investments2,503999999999   
Other noncurrent assets2502911156140140140
Other undisclosed noncurrent assets769      
Total noncurrent assets:122,58248,12946,8574,7418,1649,3093,327
TOTAL ASSETS:439,727482,567222,727213,495201,905234,583264,319
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,48113,55413,4018,6416,5305,1003,869
Accounts payable1,3872,8104,1031,7071,7311,474605
Accrued liabilities2,5672,4005,2433,9902,5401,0561,217
Employee-related liabilities9,2098,3444,0552,9442,2592,5702,047
Taxes payable1,318      
Debt 4,4734,034    
Deferred rent credit   228
Restructuring reserve     251,013
Deferred revenue and credits1,9791,946949
Other undisclosed current liabilities6,8392,8441,9731,8502,1652,825743
Total current liabilities:21,32020,87119,40810,71910,6749,8966,574
Noncurrent Liabilities
Long-term debt and lease obligation101,10826,23528,214    
Operating lease, liability101,10826,23528,214
Liabilities, other than long-term debt1,1141,1141481,6095,9537,8375,153
Deferred revenue and credits5,4727,4515,153
Deferred rent credit   1,366
Other liabilities1,1141,114148243481386 
Other undisclosed noncurrent liabilities    1,2501,250 
Total noncurrent liabilities:102,22227,34928,3621,6097,2039,0875,153
Total liabilities:123,54248,22047,77012,32817,87718,98311,727
Stockholders' equity
Stockholders' equity attributable to parent316,185434,347174,957201,167184,028215,600252,592
Common stock101076543
Additional paid in capital964,965937,134560,704522,503439,048413,518336,768
Accumulated other comprehensive loss(714)(261)(725)(799)(963)(7)(11)
Accumulated deficit(648,076)(502,536)(385,029)(320,543)(254,062)(197,915)(84,168)
Total stockholders' equity:316,185434,347174,957201,167184,028215,600252,592
TOTAL LIABILITIES AND EQUITY:439,727482,567222,727213,495201,905234,583264,319

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues7,500 2501,6121,8491,4552,319
Revenue, net1,8491,4552,319
Sublease income1,200  
Cost of revenue
(Cost of Goods and Services Sold)
   (100)(500)(600)(100)
Gross profit:7,500 2501,5121,3498552,219
Operating expenses(153,622)(117,950)(68,795)(79,693)(60,696)(116,739)(50,142)
Other undisclosed operating income   100500600100
Operating loss:(146,122)(117,950)(68,545)(78,081)(58,847)(115,284)(47,823)
Nonoperating income5821,5574,0594,2042,700762370
Foreign currency transaction loss, before tax (342)     
Other nonoperating income   4,2042,700762370
Loss from continuing operations before income taxes:(145,540)(116,393)(64,486)(73,877)(56,147)(114,522)(47,453)
Income tax expense (benefit) (1,114) 1,250 775 
Net loss available to common stockholders, diluted:(145,540)(117,507)(64,486)(72,627)(56,147)(113,747)(47,453)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(145,540)(117,507)(64,486)(72,627)(56,147)(113,747)(47,453)
Comprehensive loss:(145,540)(117,507)(64,486)(72,627)(56,147)(113,747)(47,453)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(453)46474164(956)4(21)
Comprehensive loss, net of tax, attributable to parent:(145,993)(117,043)(64,412)(72,463)(57,103)(113,743)(47,474)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: